Gerelateerd aan Academic Pharma (onder andere 3D printen).
Pharmaceutical diabetes care is described in a professional guideline. How far are these recommendations implemented in daily practice - and what are important barriers and facilitators to this?
The aim of this project is to explore the 3D printing of peadiatric medicines. 3D printing technology enables the creation of medications with a wide range of dosages, shapes, flavors, and drug combinations, all customized to meet the unique needs of individual patients and specific disease conditions. Once the optimal formulations have been developed, the 3D printed medicines will undergo clinical trials for testing.
We will study compounding medication by 3D printing technology. In this way personalized medication will become more accessable.
First formulation studies will be executed in order to provide a stable production process. After which, the use of 3D printing will be introduced in the clinical setting. Finally, the printed medication will be tested by a clinical trial.